Expertise in
15
conditions

Dr. Rabbie K. Hanna

Obstetrics and Gynecology
3990 John R St, Suite 7 Brush North, 
Detroit, MI 
Expertise in
15
conditions
3990 John R St, Suite 7 Brush North, 
Detroit, MI 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Rabbie Hanna is an Obstetrics and Gynecologist in Detroit, Michigan. Dr. Hanna is highly rated in 15 conditions, according to our data. His top areas of expertise are Endometrial Cancer, Neuroendocrine Carcinoma of the Cervix, Cervical Cancer, Hysterectomy, and Hernia Surgery.

His clinical research consists of co-authoring 22 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Obstetrics and Gynecology
Licenses
Obstetrics & Gynecology in MI
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO

Locations

3990 John R St, Suite 7 Brush North, Detroit, MI 48201

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Randomized, Phase II/III Study of Pegylated Liposomal Doxorubicin and CTEP-Supplied Atezolizumab Versus Pegylated Liposomal Doxorubicin, CTEP-Supplied Bevacizumab and CTEP-Supplied Atezolizumab Versus Pegylated Liposomal Doxorubicin and CTEP-Supplied Bevacizumab in Platinum Resistant Ovarian Cancer
A Randomized, Phase II/III Study of Pegylated Liposomal Doxorubicin and CTEP-Supplied Atezolizumab Versus Pegylated Liposomal Doxorubicin, CTEP-Supplied Bevacizumab and CTEP-Supplied Atezolizumab Versus Pegylated Liposomal Doxorubicin and CTEP-Supplied Bevacizumab in Platinum Resistant Ovarian Cancer
Enrollment Status: Active_not_recruiting
Publish Date: September 22, 2025
Intervention Type: Other, Procedure, Drug, Biological
Study Drugs: Atezolizumab, Bevacizumab, Pegylated liposomal doxorubicin hydrochloride
Study Phase: Phase 2/Phase 3
A Randomized Phase II/III Study of the Combination of Cediranib and Olaparib Compared to Cediranib or Olaparib Alone, or Standard of Care Chemotherapy in Women With Recurrent Platinum-Resistant or -Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (COCOS)
A Randomized Phase II/III Study of the Combination of Cediranib and Olaparib Compared to Cediranib or Olaparib Alone, or Standard of Care Chemotherapy in Women With Recurrent Platinum-Resistant or -Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (COCOS)
Enrollment Status: Active_not_recruiting
Publish Date: September 16, 2025
Intervention Type: Procedure, Drug, Other
Study Drugs: Cediranib, Cediranib Maleate, Olaparib, Paclitaxel, Pegylated Liposomal Doxorubicin Hydrochloride, Topotecan, Topotecan Hydrochloride
Study Phase: Phase 2/Phase 3
A Randomized, Controlled, Double-Arm, Double-Blind, Multi-Center Study of Ofranergene Obadenovec (VB-111) Combined With Paclitaxel vs. Paclitaxel Combined With Placebo for the Treatment of Recurrent Platinum-Resistant Ovarian Cancer
A Randomized, Controlled, Double-Arm, Double-Blind, Multi-Center Study of Ofranergene Obadenovec (VB-111) Combined With Paclitaxel vs. Paclitaxel Combined With Placebo for the Treatment of Recurrent Platinum-Resistant Ovarian Cancer
Enrollment Status: Completed
Publish Date: January 10, 2023
Intervention Type: Drug
Study Drugs: VB-111, Paclitaxel
Study Phase: Phase 3
Mixture of Liposomal Bupivicaine and Bupivicaine Hydrogen Chloride (HCl) May Provide Faster and Longer Lasting Analgesia in Transversus Abdominis Block for Patient Having Open Abdominal Hysterectomies
Mixture of Liposomal Bupivicaine and Bupivicaine Hydrogen Chloride (HCl) May Provide Faster and Longer Lasting Analgesia in Transversus Abdominis Block for Patient Having Open Abdominal Hysterectomies
Enrollment Status: Completed
Publish Date: December 21, 2022
Intervention Type: Drug
Study Phase: Phase 4
View 3 Less Clinical Trials

22 Total Publications

Randomized phase II trial of farletuzumab plus chemotherapy versus placebo plus chemotherapy in low CA-125 platinum-sensitive ovarian cancer.
Randomized phase II trial of farletuzumab plus chemotherapy versus placebo plus chemotherapy in low CA-125 platinum-sensitive ovarian cancer.
Journal: Gynecologic oncology
Published: October 13, 2022
Similar Doctors
Expertise in
9
conditions
Dr. Hope K. Haefner
Obstetrics and Gynecology
Expertise in
9
conditions
Dr. Hope K. Haefner
Obstetrics and Gynecology

Regents Of The University Of Michigan

4270 Plymouth Rd, 
Ann Arbor, MI 
 (31.6 miles away)
734-936-4000
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Hope Haefner is an Obstetrics and Gynecologist in Ann Arbor, Michigan. Dr. Haefner is highly rated in 9 conditions, according to our data. Her top areas of expertise are Vulvodynia, Lichen Sclerosus, Lichen Planus, Vitiligo, and Vulvectomy. Dr. Haefner is currently accepting new patients.

Expertise in
13
conditions
Dr. Ira S. Winer
Gynecologic Oncology | Obstetrics and Gynecology | Oncology
Expertise in
13
conditions
Dr. Ira S. Winer
Gynecologic Oncology | Obstetrics and Gynecology | Oncology

University Physician Group

4100 John R St, 
Detroit, MI 
 (0.1 miles away)
800-527-6266
Languages Spoken:
English, Hebrew
See accepted insurances
Accepting New Patients
Offers Telehealth

Ira Winer is a Gynecologic Oncologist and an Obstetrics and Gynecologist in Detroit, Michigan. Dr. Winer is highly rated in 13 conditions, according to our data. His top areas of expertise are Ovarian Cancer, Endometrial Cancer, Vulvar Cancer, Vaginectomy, and Tubal Ligation. Dr. Winer is currently accepting new patients.

Expertise in
7
conditions
Dr. Erica E. Marsh
Obstetrics and Gynecology | Reproductive Medicine
Expertise in
7
conditions
Dr. Erica E. Marsh
Obstetrics and Gynecology | Reproductive Medicine

Regents Of The University Of Michigan

475 Market Pl, 
Ann Arbor, MI 
 (35.8 miles away)
734-763-4323
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Erica Marsh is an Obstetrics and Gynecologist and a Reproductive Medicine provider in Ann Arbor, Michigan. Dr. Marsh is highly rated in 7 conditions, according to our data. Her top areas of expertise are Uterine Fibroids, Infertility, Menorrhagia, Hysterectomy, and Intrauterine Device Insertion. Dr. Marsh is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Hanna's expertise for a condition
ConditionClose
    View All 9 Advanced Conditions
    View All 7 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile